Literature DB >> 19104753

Radiographic progression in weight-bearing joints of patients with rheumatoid arthritis after TNF-blocking therapies.

Eiko Seki1, Isao Matsushita, Eiji Sugiyama, Hirohumi Taki, Koichiro Shinoda, Hiroyuki Hounoki, Hiraku Motomura, Tomoatsu Kimura.   

Abstract

The aim of the present study was to assess the influence of tumor necrosis factor (TNF)-blocking therapies on weight-bearing joints in patients with rheumatoid arthritis. Changes in clinical variables and radiological findings in 213 weight-bearing joints (69 hip joints, 63 knee joints, and 81 ankle joints) of 42 consecutive patients were investigated at baseline and at 1 year of TNF-blocking therapies. Structural damage to the weight-bearing joints was assessed using the Larsen scoring method. Detailed comparisons of the sizes and locations of erosions were performed for each set of radiographs of the respective joints. Assessment of radiographs of the 213 weight-bearing joints indicated progression of the Larsen grade in eight joints. Another five joints without Larsen grade progression showed apparent radiographic progression of joint damage based on increases in bony erosions. Overall, 13 joints (6%) of eight patients (19%) showed progression of joint damage after 1 year of TNF-blocking therapies. Analysis of each baseline grade indicated that radiographic progression of joint damage was inhibited in most grade 0-II joints. On the other hand, all hip and knee joints with pre-existing damage of grade III/IV showed apparent progression even in patients with good response. The results further suggested that radiographic progression may occur in less damaged joints when the patients were non-responders to the therapy. Among the weight-bearing joints, ankle joints showed different radiographic behavior and four ankle joints displayed improvement of radiographic damage. Early initiation of anti-TNF therapy should be necessary especially when the patients are starting to show early structural damage in weight-bearing joints.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19104753     DOI: 10.1007/s10067-008-1076-9

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  27 in total

1.  Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.

Authors:  P E Lipsky; D M van der Heijde; E W St Clair; D E Furst; F C Breedveld; J R Kalden; J S Smolen; M Weisman; P Emery; M Feldmann; G R Harriman; R N Maini
Journal:  N Engl J Med       Date:  2000-11-30       Impact factor: 91.245

2.  Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score.

Authors:  D M van der Heijde; M A van 't Hof; P L van Riel; L A Theunisse; E W Lubberts; M A van Leeuwen; M H van Rijswijk; L B van de Putte
Journal:  Ann Rheum Dis       Date:  1990-11       Impact factor: 19.103

3.  Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films.

Authors:  A Larsen; K Dale; M Eek
Journal:  Acta Radiol Diagn (Stockh)       Date:  1977-07

4.  The long-term results of ankle joint synovectomy for rheumatoid arthritis.

Authors:  S Akagi; H Sugano; R Ogawa
Journal:  Clin Rheumatol       Date:  1997-05       Impact factor: 2.980

5.  Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial.

Authors:  Y P M Goekoop-Ruiterman; J K de Vries-Bouwstra; C F Allaart; D van Zeben; P J S M Kerstens; J M W Hazes; A H Zwinderman; H K Ronday; K H Han; M L Westedt; A H Gerards; J H L M van Groenendael; W F Lems; M V van Krugten; F C Breedveld; B A C Dijkmans
Journal:  Arthritis Rheum       Date:  2005-11

6.  The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis.

Authors:  P M Welsing; A M van Gestel; H L Swinkels; L A Kiemeney; P L van Riel
Journal:  Arthritis Rheum       Date:  2001-09

7.  Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

Authors:  M L Prevoo; M A van 't Hof; H H Kuper; M A van Leeuwen; L B van de Putte; P L van Riel
Journal:  Arthritis Rheum       Date:  1995-01

8.  Disconnect between inflammation and joint destruction after treatment with etanercept plus methotrexate: results from the trial of etanercept and methotrexate with radiographic and patient outcomes.

Authors:  Robert Landewé; Désirée van der Heijde; Lars Klareskog; Ronald van Vollenhoven; Saeed Fatenejad
Journal:  Arthritis Rheum       Date:  2006-10

9.  The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment.

Authors:  Ferdinand C Breedveld; Michael H Weisman; Arthur F Kavanaugh; Stanley B Cohen; Karel Pavelka; Ronald van Vollenhoven; John Sharp; John L Perez; George T Spencer-Green
Journal:  Arthritis Rheum       Date:  2006-01

10.  Effects of exercise on synovium and cartilage from normal and inflamed knees.

Authors:  A K Shay; M L Bliven; D N Scampoli; I G Otterness; A J Milici
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631

View more
  12 in total

1.  Reparative radiological changes of a large joint after adalimumab for rheumatoid arthritis.

Authors:  Shigeki Momohara; Eiichi Tanaka; Takuji Iwamoto; Katsunori Ikari; Hisashi Yamanaka
Journal:  Clin Rheumatol       Date:  2011-02-12       Impact factor: 2.980

2.  Inhibitory effect of JAK inhibitor on mechanical stress-induced protease expression by human articular chondrocytes.

Authors:  Takahiro Machida; Keiichiro Nishida; Yoshihisa Nasu; Ryuichi Nakahara; Masatsugu Ozawa; Ryozo Harada; Masahiro Horita; Ayumu Takeshita; Daisuke Kaneda; Aki Yoshida; Toshifumi Ozaki
Journal:  Inflamm Res       Date:  2017-07-27       Impact factor: 4.575

3.  The Influence of Rheumatoid Arthritis on Higher Reoperation Rates over Time Following Lumbar Spinal Fusion-A Nationwide Cohort Study.

Authors:  Jin-Sung Park; Se-Jun Park; Jiwon Park; Gijun Shin; Jae-Young Hong
Journal:  J Clin Med       Date:  2022-05-16       Impact factor: 4.964

4.  Knee joint destruction driven by residual local symptoms after anti-tumor necrosis factor therapy in rheumatoid arthritis.

Authors:  Takashi Imagama; Hiroshi Tanaka; Atsunori Tokushige; Kazushige Seki; Seiji Sumiura; Manabu Yamamoto; Yukio Nagahiro; Toshihiko Taguchi
Journal:  Clin Rheumatol       Date:  2013-02-02       Impact factor: 2.980

5.  Scoring evaluation for histopathological features of synovium in patients with rheumatoid arthritis during anti-tumor necrosis factor therapy.

Authors:  Hajime Yamanaka; Ken-ichiro Goto; Kazutoshi Miyamoto
Journal:  Rheumatol Int       Date:  2010-01       Impact factor: 2.631

6.  Oral steroid decreases the progression of joint destruction of large joints in the lower extremities in rheumatoid arthritis.

Authors:  K Doi; H Ito; T Tomizawa; K Murata; M Hashimoto; M Tanaka; K Murakami; K Nishitani; M Azukizawa; A Okahata; M Saito; T Mimori; S Matsuda
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

7.  Accelerated development of cervical spine instabilities in rheumatoid arthritis: a prospective minimum 5-year cohort study.

Authors:  Takashi Yurube; Masatoshi Sumi; Kotaro Nishida; Hiroshi Miyamoto; Kozo Kohyama; Tsukasa Matsubara; Yasushi Miura; Hiroaki Hirata; Daisuke Sugiyama; Minoru Doita
Journal:  PLoS One       Date:  2014-02-18       Impact factor: 3.240

8.  Prediction of Large Joint Destruction in Patients With Rheumatoid Arthritis Using 18F-FDG PET/CT and Disease Activity Score.

Authors:  Takahito Suto; Koichi Okamura; Yukio Yonemoto; Chisa Okura; Yoshito Tsushima; Kenji Takagishi
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

Review 9.  Control of articular synovitis for bone and cartilage regeneration in rheumatoid arthritis.

Authors:  Hiromu Ito; Furu Moritoshi; Motomu Hashimoto; Masao Tanaka; Shuichi Matsuda
Journal:  Inflamm Regen       Date:  2018-04-16

10.  Change of ARASHI scores for large joints in rheumatoid arthritis patients treated with abatacept for three years: A clinical observational study.

Authors:  Takeshi Mochizuki; Koichiro Yano; Katsunori Ikari; Ryo Hiroshima; Mina Ishibashi; Ken Okazaki
Journal:  Arch Rheumatol       Date:  2020-06-25       Impact factor: 1.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.